Literature DB >> 16806929

Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.

M Baris Baslo1, Feza Deymeer, Piraye Serdaroglu, Yesim Parman, Coskun Ozdemir, Marina Cuttini.   

Abstract

The decrement pattern at low rates of repetitive nerve stimulation in myasthenia gravis (MG) is characterized by a decrease of compound muscle action potential size within the first 4-5 responses. With subsequent stimuli, compound muscle action potential size either increases or does not change. Following an observation that the pattern of decrement might be different in patients with Lambert-Eaton myasthenic syndrome (LEMS), we retrospectively studied traces from eight LEMS patients and 14 patients with seropositive generalized MG, calculating decrement percent from first to fourth and from first to ninth compound muscle action potential. In the LEMS patients, compound muscle action potential amplitude decreased progressively from first to ninth stimulus at 2, 3 or 5Hz in all traces but one. In contrast, MG patients demonstrated the expected improvement after the initial decrement in all traces except one. In the evaluation of patients suspected of having myasthenia gravis, the finding of progressive decrement pattern at low rates of repetitive nerve stimulation may alert the electromyographer to the possibility of Lambert-Eaton syndrome and prompt the performance of further electrodiagnostic tests.

Entities:  

Mesh:

Year:  2006        PMID: 16806929     DOI: 10.1016/j.nmd.2006.05.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Authors:  Francesc Miralles
Journal:  Med Biol Eng Comput       Date:  2016-03-25       Impact factor: 2.602

2.  CMAP decrement by low-frequency repetitive nerve stimulation in different hand muscles of ALS patients.

Authors:  Dong Zhang; Yuying Zhao; Chuanzhu Yan; Lili Cao; Wei Li
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

Review 3.  History of Myasthenia Gravis Revisited.

Authors:  Feza Deymeer
Journal:  Noro Psikiyatr Ars       Date:  2020-11-07       Impact factor: 1.339

Review 4.  Lambert-Eaton Myasthenic syndrome: early diagnosis is key.

Authors:  Trajche Ivanovski; Francesc Miralles
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.